Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GPRE | CE |
|---|---|---|
| Price | $15.34 | $43.86 |
| Change today | ▲ 1.19% | ▼ 2.21% |
| Market cap | $1.08B | $4.81B |
| Return, 3 months | -7.8% | -5.9% |
| Return, year to date | +56.5% | +3.9% |
| Return, 1 year | +49.2% | +3.1% |
| P/E (TTM) | 9.2 | -4.1 |
| P/B | 1.2 | 1.2 |
| P/E percentile vs own 5y | 99th | 12th |
| Dividend yield | – | 0.27% |
| Revenue growth (YoY, latest qtr) | -19.3% | +8.7% |
| Net profit growth (YoY) | +193.0% | -35.5% |
| Gross margin | 16.0% | 20.9% |
| Operating margin | 5.7% | 8.4% |
| Net margin | 6.8% | -12.0% |
| Return on equity | 15.4% | -24.8% |
| Analyst target vs. price | +23.9% | +34.3% |
| Analyst buy share | 33% | 58% |
| RSI (14) | 53 | 43 |
| 30-day volatility | 33.6% | 41.3% |
| Max drawdown, 1 year | -27.0% | -37.7% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
